Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Amod Tilak"'
1
Akademický článek
A Rare Instance of Levofloxacin Induced Myoclonus
Autor: Sushil Kiran Kunder, A. Avinash, Veena Nayak, Amod Tilak
Publikováno v: Journal of Clinical and Diagnostic Research, Vol 11, Iss 7, Pp FD01-FD02 (2017)
Levofloxacin is a widely used fluoroquinolone, mainly as a respiratory antimicrobial agent. It is employed as a second line therapeutic modality in pulmonary tuberculosis as well. The drug has been in use for ages, and is known to be both efficaciou
Externí odkaz: https://doaj.org/article/759fd2cf208844f69dc022a30766097b
Zobrazit plný text záznamu
2
Akademický článek
A Retrospective Study to Assess the Effect of Proton Pump Inhibitors on Renal Profile in a South Indian Hospital
Autor: A. Avinash, Navin Patil, Sushil Kiran Kunder, O. Balaji, Amod Tilak, Ravi K. Sori, Raghavendra Rao
Publikováno v: Journal of Clinical and Diagnostic Research, Vol 11, Iss 4, Pp FC09-FC12 (2017)
Introduction: Proton Pump Inhibitors (PPIs) are arguably among the most commonly prescribed drugs in clinical practice, either as part of treatment or prophylaxis. Many clinicians prescribe these drugs as part of any prescription, without a proper
Externí odkaz: https://doaj.org/article/77434ef6581b4d1a8f46401446e3383b
Zobrazit plný text záznamu
4
Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus
Autor: Abhishek De, Nidhi Sharma, Samipa Mukherjee, Sharad Mutalik, Amar J. Chitkara, Murlidhar Rajagopalan, Ram Gulati, Prakash Vaidya, Samir Dalwai, Shrutakirthi D Shenoi, Amod Tilak, Charles Adhav
Publikováno v: Clinical, Cosmetic and Investigational Dermatology
Murlidhar Rajagopalan,1 Amar Jeet Chitkara,2 Samir Dalwai,3 Abhishek De,4 Ram Gulati,5 Samipa Mukherjee,6 Sharad Mutalik,7 Nidhi Sharma,8 Shrutakirthi Shenoi,9 Prakash Vaidya,10 Amod Tilak,11 Charles Adhav11 1Department of Dermatology, Apollo Hospita
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22eb080fc2358e8fe5246e2948acd57b
https://www.dovepress.com/burden-of-disease-unmet-needs-in-the-diagnosis-and-management-of-atopi-peer-reviewed-fulltext-article-CCID
Zobrazit plný text záznamu
5
Successful emergency surgery in a patient on dabigatran, after reversing the anticoagulation effect using Idarucizumab – A case report
Autor: Arun Kumar Dahiya, Prakash Valse, Amod Tilak, Annapurna Kalia, Rajesh Badani
Publikováno v: IP Journal of Surgery and Allied Sciences. 2:120-122
Surgeons are required to keep themselves updated on ever-increasing list of drugs that may influence the outcomes of surgeries, especially in an emergency scenario. Here, we report a case of acute abdomen, wherein the patient was on dabigatran, a ‘
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a695f9327d8fb041fd0982b1714b764
https://doi.org/10.18231/j.jsas.2020.021
Zobrazit plný text záznamu
6
Successful intravenous thrombolysis in a patient with ischemic stroke, after reversal of Dabigatran with Idarucizumab – A case report
Autor: Amod Tilak, Gajanan Patil, Nasli R Ichaporia, Arun Kumar Dahiya, Sanjay Pawar
Publikováno v: IP Indian Journal of Neurosciences. 6:327-329
There remains a risk of ischemic strokes in patients of atrial fibrillation receiving oral anticoagulants. Systemic thrombolysis in such cases poses a challenge, but may be possible after reversal of anticoagulant effect. We report a case of 61-year
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09d2f22f8decb43ea81773793bca9e2e
https://doi.org/10.18231/j.ijn.2020.059
Zobrazit plný text záznamu
7
Reversal of the anticoagulant effect of direct thrombin inhibitor dabigatran etexilate in acute ischemic stroke and intracranial hemorrhage using idarucizumab – A case study
Autor: Amod Tilak, Sonesh Kalra, Nasli R Ichaporia, Ashutosh N Shetty
Publikováno v: IP Indian Journal of Neurosciences. 5:176-180
The non-Vitamin K oral anticoagulants (NOACs) help prevent stroke in patients of atrial fibrillation. However, management of patients on NOACs in emergency situations is a challenging prospect. Idarucizumab is approved globally as well as in India as
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d2efb4ef36e6871b258c686904302a1
https://doi.org/10.18231/j.ijn.2019.028
Zobrazit plný text záznamu
8
Opportunistic infection at the start of antiretroviral therapy and baseline CD4+ count less than 50 cells/mm3 are associated with poor immunological recovery
Autor: Kavitha Saravu, Smita Shenoy, Amruta Tripathy, Amod Tilak, Muralidhar Varma, Asha Kamath, Ravi K Sori
Publikováno v: Journal of Basic and Clinical Physiology and Pharmacology. 30:163-171
IntroductionThere is a dearth of studies assessing the efficacy and immunological improvement in patients started on antiretroviral therapy (ART) in India. This study was undertaken to assess the 2-year treatment outcomes in HIV-positive patients ini
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c8ca0f3849d48a38242ba1ba92a11ae
https://doi.org/10.1515/jbcpp-2018-0105
Zobrazit plný text záznamu
9
EFFECT OF LEVETIRACETAM ON HEALING OF EXCISION AND BURN WOUND MODELS IN WISTAR RATS
Autor: Amod Tilak, Balaji O, Huba Kh Rashid, Navin Patil
Publikováno v: Asian Journal of Pharmaceutical and Clinical Research. :82-85
Objective: Levetiracetam (LEV) at lower doses (50 and 100 μg/ml) has demonstrated antioxidant effect as per literature evidence. Hence, the aim of current study was to evaluate the action of LEV on wound healing with regard to its antioxidant proper
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d048a4ab87edca9a5976b3ea3d175bce
https://doi.org/10.22159/ajpcr.2019.v12i3.27916
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje